Baldrige Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$6K Hold
75
﹤0.01% 284
2022
Q4
$6K Hold
75
﹤0.01% 265
2022
Q3
$6K Hold
75
﹤0.01% 260
2022
Q2
$7K Sell
75
-379
-83% -$38.4K ﹤0.01% 261
2022
Q1
$50K Buy
454
+379
+505% +$40K 0.02% 178
2021
Q4
$8K Sell
75
-613
-89% -$71K ﹤0.01% 279
2021
Q3
$86K Sell
688
-809
-54% -$105K 0.04% 137
2021
Q2
$186K Buy
+1,497
New +$188K 0.08% 103
2019
Q3
Sell
-2,521
Closed -$246K 83
2019
Q2
$246K Hold
2,521
0.23% 64
2019
Q1
$230K Buy
+2,521
New +$226K 0.22% 61

Other funds holding MDT

Baldrige Asset Management's MDT Position: Q1 2023 in Review

Baldrige Asset Management held its Medtronic (MDT) position steady in Q1 2023 at 75 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

Baldrige Asset Management first reported a position in MDT in Q1 2019 and has held it in 10 quarters since. The position peaked at $246K in Q2 2019. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Baldrige Asset Management held 75 shares of Medtronic worth $6K as of Q1 2023.
  • Baldrige Asset Management left its Medtronic share count unchanged in Q1 2023.
  • Medtronic made up ﹤0.01% of Baldrige Asset Management's portfolio in Q1 2023, its #284 holding.
  • Baldrige Asset Management first reported a position in Medtronic in Q1 2019 and has held it in 10 quarters since.
  • Baldrige Asset Management's Medtronic position peaked at $246K in Q2 2019.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.